Treatment‐resistant schizophrenia with 22q11.2 deletion and additional genetic defects
Abstract We report a case of a 61‐year‐old female with 22q11.2 deletion syndrome (22q11.2DS) and a novel heterozygous nonsense variant in MAP1A, identified through whole‐genome sequencing (WGS). The patient presented with intellectual developmental disorder, treatment‐resistant schizophrenia (SCZ),...
Saved in:
| Main Authors: | Sawako Furukawa, Shusei Arafuka, Hidekazu Kato, Tomoo Ogi, Norio Ozaki, Masashi Ikeda, Itaru Kushima |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2024-12-01
|
| Series: | Neuropsychopharmacology Reports |
| Subjects: | |
| Online Access: | https://doi.org/10.1002/npr2.12477 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Treatment of 22q11.2 deletion syndrome-associated schizophrenia with comorbid anxiety and panic disorder
by: Candace B. Borders, et al.
Published: (2017-10-01) -
Systemic lupus erythematosus in a patient with 22q11.2 deletion syndrome: A case report and review of the literature
by: Chen Sun, et al.
Published: (2024-11-01) -
Characteristics of velopharyngeal dysfunction in 22q11.2 deletion syndrome: a retrospective case-control study
by: Sebastiano Failla, et al.
Published: (2020-07-01) -
Prevalence of immunological aberrations and 22q11.2 deletion in children with conotruncal anomalies: A cross-sectional study
by: Souvik Das, et al.
Published: (2024-12-01) -
Driving Innovation to Support Pupils with SEND Through Co-Production in Education and Research: Participatory Action Research with 22q11.2 Deletion Syndrome Families in England
by: Michelle Jayman, et al.
Published: (2024-12-01)